Zealand Pharma announces successful outcome of Phase 1b clinical trial with GLP1-GLP2 dual receptor agonist, dapiglutide

https://www.globenewswire.com/news-release/2021/11/22/2339043/0/en/Zealand-Pharma-announces-successful-outcome-of-Phase-1b-clinical-trial-with-GLP1-GLP2-dual-receptor-agonist-dapiglutide.html

company announcement